Gene–Environment Interactions: A Review of Effects on Reproduction and Development

REFERENCES

• Cavelli-Sforza L. L., Bodmer W. F.. 1971; The Genetics of Human Populations. 118, San Francisco, W. H. Freeman
   Google Scholar
• Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C.. 1989. Identification of the cystic fibrosis gene: Genetic analysis. Science2451073
   PubMedGoogle Scholar
• Collins F. S., Brooks L. D., Chakravarti A.. 1998. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res.. 8: 1229, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ottman R.. 1996. Gene–environment interaction: Definitions and study designs. Prev. Med.. 25: 764, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vineis P.. 2002. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology. 181–182: 457, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mucci L. A., Wedren S., Tamimi R. M., Trichopoulos D., Adami H. O.. 2001. The role of gene–environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung and breast. J. Intern. Med.. 249: 477, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Talmud P. J., Hawe E., Miller G. J.. 2002. Analysis of gene-environment interaction in coronary artery disease: Lipoprotein lipase and smoking as examples. Ital. Heart J.. 3: 6, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Cortese C., Motti C.. 2001. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr. 4: 493, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Brown P. O., Hartwell L.. 1998. Genomics and human disease—Variations on variation. Nat. Genet.. 18: 91, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barron W. M.. 1992. The syndrome of preeclampsia. Gastroenterol. Clin. North Am.. 21: 851, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kim Y. J., Williamson R. A., Chen K., Smith J. L., Murray J. C., Merrill D. C.. 2001. Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension. 38: 992, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Witt C. S., Whiteway J. M., Warren H. S., Barden A., Rogers M., Martin A., Beilin L., Christiansen F. T.. 2002. Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur. J. Immunol.. 32: 18, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Liao W.-X., Roy A. C.. 2002. Lack of association between polymorphisms in the testis-specific angiotensin converting enzyme gene and male infertility in an Asian population. Mol. Hum. Reprod.. 8: 299, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Orioli I. M., Vieira A. R., Castilla E. E., Ming J. E., Muenke M.. 2002. Mutational analysis of the Sonic Hedgehog gene in 220 newborns with oral clefts in a South American (ECLAMC) population. Am. J. Med. Genet.. 108: 12, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Leveille-Webster C. R., Arias I. M.. 1995. The biology of the P-glycoproteins. J. Membr. Biol.. 143: 89, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chin J. E., Soffir R., Noonan K. E., Choi K., Roninson I. B.. 1989. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell Biol.. 9: 3808, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Croop J. M., Raymond M., Haber D., Devault A., Arceci R. J., Gros P., Housman D.. 1989. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell Biol.. 9: 1346, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schinkel A. H., Smit J. J., van, Tellingen O., Beijnen J. H., Wagenaar E., van, Deemter L., Mol C. A., van der, Valk M. A., Robanus-Maandag E. C., te, Riele H. P., Berns A. J., Borst P.. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell. 77: 491, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R.. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA. 86: 695, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M., Pastan I., Willingham M. C.. 1987. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA. 84: 7735, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Umbenhauer D., Lankas G. R., Pippert T., Wise L. D., Cartwright M. E., Hall S. J., Beare C. M.. 1997. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol.. 146: 88, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lankas G. R., Wise L. D., Cartwright M. E., Pippert T., Umbenhauer D.. 1998. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol.. 12: 457, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Arceci R. J., Croop J. M., Horwitz S. B., Housman D.. 1988. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA. 85: 4350, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Smit J. W., Huisman M. T., van, Tellingen O., Wiltshire H. R., Schinkel A. H.. 1999. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest.. 104: 1441, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cagen S. Z., Waechter J. M., Dimond S. S., Breslin W. J., Butala J. H., Jekat F. W., Joiner R. L., Shiotsuka R. N., Veenstra G. E., Harris L. R.. 1999. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol. Sci.. 50: 36, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• MacFarland A., Abramovich D. R., Ewen S. W., Pearson C. K.. 1994. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem. J.. 26: 417, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Nakamura Y., Ikeda S., Furukawa T., Sumizawa T., Tani A., Akiyama S., Nagata Y.. 1997. Function of P-glycoprotein expressed in placenta and mole. Biochem. Biophys. Res. Commun.. 235: 849, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Czeizel A. E., Dudas I.. 1992. Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N. Engl. J. Med.. 327: 1832, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Laurence K. M., James N., Miller M., Tennant G. B., Campbell H.. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J.. 282: 1509
   PubMed Web of Science ®Google Scholar
• Smithells R. W., Nevin N. C., Seller M. J., Sheppard S., Harris R., Read A. P., Fielding D. W., Walker S., Schorah C. J., Wild J.. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1: 1027, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kirke P. N., Daly L. E., Elwood J. H.. 1920. A randomised trial of low dose folic acid to prevent neural tube defects. Arch. Dis. Child.. 67: 1442
   Google Scholar
• Williams L. J., Mai C. T., Edmonds L. D., Shaw G. M., Kirby R. S., Hobbs C., Sever L. E., Miller L. A., Meaney F. J., Levitt M.. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 66: 33, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Fodinger M., Horl W. H., Sunder-Plassmann G.. 2000. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J. Nephrol.. 13: 20, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Whitehead A. S., Gallagher P., Mills J. L., Kirke P. N., Burke H., Molloy A. M., Weir D. G., Shields D. C., Scott J. M.. 1995. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med.. 88: 763
   Google Scholar
• van der, Put N. M. J., Blom H. J.. 2000. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur. J. Obstet. Gyn. Res. Bull.. 92: 57, [CROSSREF]
   PubMedGoogle Scholar
• Daly L. E., Kirke P. N., Molloy A. M., Weir D. G., Scott J. M.. 1995. Folate levels and neural tube defects: Implications for prevention. J. Am. Med. Assoc.. 274: 1698, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moyers S., Bailey L. B.. 2001. Fetal malformations and folate metabolism: Review of recent evidence. Nutr. Rev.. 59: 215, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Botto L. D., Yang Q.. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am. J. Epidemiol.. 151: 862, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• van der, Put N., Steegers-Theunissen R. P., Frosst P., Trijbels F. J., Eskes T. K., van den, Heuvel L. P., Mariman E. C., den, Heyer M., Rozen R., Blom H. J.. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346: 1070, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• van der, Put N., Gabreels F. J., Stevens E., Smeitink J. A., Trijbels F. J., Eskes T. K., van den, Heuvel L. P., Blom H. J.. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects?. Am. J. Hum. Genet.. 62: 1044, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Shaw G. M., Rozen R., Finnell R. H., Wasserman C. R., Lammer E. J.. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am. J. Epidemiol.. 148: 30, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kirke P. N., Mills J. L., Whitehead A. S., Molloy A. M., Scott J. M.. 1996. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet. 348: 1037, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ou C. Y., Stevenson R. E., Brown V. K., Schwartz C. E., Allen W. P., Khoury M. J., Rozen R., Oakley G. P., Adams M. J.. 1996. 5,10-methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet.. 63: 610, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Molloy A. M., Mills J. L., Kirke P. N., Ramsbottom D., Mcpartlin J. M., Burke H., Conley M. R., Whitehead A. S., Weir D. G., Scott J. M.. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile methylenetetrahydrofolate reductase: Low folate status alone may be the critical factor. Am. J. Genet.. 78: 155, [CROSSREF]
   Google Scholar
• Papapetrou C., Lynch S. A., Burn J., Edwards Y. H.. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet. 348: 58, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mornet E., Muller F., Lenvoise-Furet A., Delezoide A.-L., Col J. Y., Simon-Bouy B., Serre J. L.. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum. Genet.. 100: 512, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shaw G. M., Rozen R., Finnell R. H., Todoroff K., Lammer E. J.. 1998. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am. J. Med. Genet.. 80: 196, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mills J. L., Kirke P. N., Molloy A. M., Burke H., Conley M. R., Lee Y. J., Mayne P. D., Weir D. G., Scott J. M.. 1999. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am. J. Med. Genet.. 86: 71, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• James S. J., Pogribna M., Pogribny I. P., Melnyk S., Hine R. J., Gibson J. B., Yi P., Tafoya D. L., Swenson D. H., Wilson V. L., Gaylor D. W.. 1999. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am. J. Clin. Nutr.. 70: 495, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hobbs C., Sherman S. L., Yi P., Hopkins S. E., Torfs C. P., Hine R. J., Pogribna M., Rozen R., James S. J.. 2000. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet.. 67: 623, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• MRC Vitamin Study Research Group, 1991. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet. 338: 131, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Christensen B., Arbour L., Tran P., Leclerc D., Sabbaghian N., Platt R., Gilfix B. M., Rosenblatt D. S., Gravel R. A., Forbes P., Rozen R.. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet.. 84: 151, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rosenquist T. H., Ratashak S. A., Selhub J.. 1996. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc. Natl. Acad. Sci. USA. 93: 15227, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Iamaroon A., Tait B., Diewert V. M.. 1996. Cell proliferation and expression of EGF, TGF alpha, and EGF receptor in the developing primary palate. J. Dent. Res.. 75: 1534, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Dixon M. J., Garner J., Ferguson M. W.. 1991. Immunolocalization of epidermal growth factor (EGF), EGF receptor and transforming growth factor alpha (TGF alpha) during murine palatogenesis in vivo and in vitro. Anat. Embryol.. 184: 83, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Machida J., Yoshiura K., Funkhauser C. D., Natsume N., Kawai T., Murray J. C.. 1999. Transforming growth factor-alpha (TGFA): Genomic structure, boundary sequences, and mutation analysis in nonsyndromic cleft lip/palate and cleft palate only. Genomics. 61: 237, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Jara L., Blanco R., Chiffelle I., Palomino H., Carreno H.. 1995. Association between alleles of the transforming growth factor alpha locus and cleft lip and palate in the Chilean population. Am. J. Med. Genet.. 57: 548, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Feng H., Sassani R., Bartlett S. P., Lee A., Hecht J. T., Malcom S., Winter R. M. W., Vintiner G. M., Buetow K. H., Gasser D. L.. 1994. Evidence, from family studies, for linkage disequilibrium between TGFA and a gene for nonsyndromic cleft lip with or without cleft palate. Am. J. Hum. Genet.. 55: 932, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lidral A. C., Romitti P. A., Basart A. M., Doetschman T., Leysens N. J., Daack-Hirsch S., Semina E. V., Johnson L. R., Machida J., Burds A., Parnell T. J., Rubenstein J. L. R., Murray J. C.. 1998. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am. J. Hum. Genet.. 63: 557, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Field L. L., Ray A. K., Marazita M. L.. 1994. Transforming growth factor alpha: A modifying locus for nonsyndromic cleft lip with or without cleft palate?. Eur. J. Hum. Genet.. 2: 159, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Scapoli L., Pezzetti F., Carinci F., Martinelli M., Carinci P., Tognon M.. 1998. Lack of linkage disequilibrium between transforming growth factor alpha Taq 1 polymorphism and cleft lip with or without cleft palate in families from Northeastern Italy. Am. J. Med. Genet.. 75: 203, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mitchell L. E.. 1997. Transforming growth factor alpha locus and nonsyndromic cleft lip with or without cleft palate: A reappraisal. Genet. Epidemiol.. 14: 231, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kallen K.. 1997. Maternal smoking and orofacial clefts. Cleft Palate–Cran. J.. 34: 11, [CROSSREF]
   PubMedGoogle Scholar
• Lorente C., Cordier S., Goujard J., Segolene A., Bianchi F., Calzolari E., De, Walle H. E. K., Knill-Jones R.. Occupational Exposure and Congenital Malformations Working Group. 2000. Tobacco and alcohol use during pregnancy and risk of oral clefts. Am. J. Public Health. 90: 415, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chung K. C., Kowalski C. P., Kim H. M., Buchman S. R.. 2000. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast. Reconstr. Surg.. 105: 485, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Khoury M. J., Weinstein A., Panny S., Holtzman N. A., Lindsay P. K., Farrel K., Eisenberg M.. 1987. Maternal cigarette smoking and oral clefts: A population-based study. Am. J. Public Health. 77: 623, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Werler M. M., Lammer E. J., Rosenberg L., Mitchell A. A.. 1990. Maternal cigarette smoking during pregnancy in relation to oral clefts. Am. J. Epidemiol.. 132: 926, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lieff S., Olshan A. F., Werler M. M., Strauss R. P., Smith J., Mitchell A. A.. 1999. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns. Am. J. Epidemiol.. 150: 683, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wyszynski D. F., Duffy D. L., Beaty T. H.. 1997. Maternal cigarette smoking and oral clefts: A meta-analysis. Cleft Palate–Cran. J.. 34: 206, [CROSSREF]
   PubMedGoogle Scholar
• Hwang S.-J., Beaty T. H., Panny S. R., Street N. A., Joseph J. M., Gordon S., McIntosh I., Francomano C. A.. 1995. Association study of transforming growth factor alpha (TGFalpha) Taq1 polymorphism and oral clefts: Indication of gene–environment interaction in a population-based sample of infants with birth defects. Am. J. Epidemiol.. 141: 629, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shaw G. M., Wasserman C. R., Lammer E. J., O'Malley C. D., Murray J. C., Basart A. M., Tolarova M. M.. 1996. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am. J. Hum. Genet.. 58: 551, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Maestri N. E., Beaty T. H., Hetmanski J., Smith E. A., McIntosh I., Wyszynski D. F., Liang K.-Y., Duffy D. L., VanderKolk C.. 1997. Application of transmission disequilibrium tests to nonsyndromic oral clefts. Am. J. Med. Genet.. 73: 337, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Romitti P. A., Lidral A. C., Munger R. G., Daack-Hirsch S., Burns T. L., Murray J. C.. 1999. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype–environment interactions from a population-based case-control study of orofacial clefts. Teratology. 59: 39, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• van, Rooij I. A., Wegerif M., Roelofs H., Peters W. H., Kuijpers-Jagtman A.-M., Zielhuis G. A., Merkus H. M., Steegers-Theunissen R. P.. 2001. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: A gene–environment interaction. Epidemiology. 12: 502, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Christensen K., Olsen J., Norgaard-Pedersen B., Basso O., Stovring H., Milhollin-Johnson L., Murray J. C.. 1999. Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: A population-based case control study in Denmark, 1991–1994. Am. J. Epidemiol.. 149: 248, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fitzpatrick D. R., Denhez F., Kondaiah P., Akhurst R. J.. 1990. Differential expression of TGF beta isoforms in murine palatogenesis. Development. 109: 585, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Abbott B. D., Probst M. R., Perdew G. H., Buckalew A. R.. 1998. AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology. 58: 30, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Clarren S. K., Smith D. W.. 1978. The fetal alcohol syndrome. N. Engl. J. Med.. 298: 1063, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chernoff G. F.. 1980. The fetal alcohol syndrome in mice: Maternal variables. Teratology. 22: 71, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Agarwal D. P.. 2001. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol.. 49: 703, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bosron W. F., Li T.-K.. 1986. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology. 6: 502, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McCarver D. G., Byun R., Hines R., Hichme M., Wegenek W.. 1998. A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol.. 152: 276, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McCarver D. G.. 2001. ADH2 and CYP2E1 genetic polymorphisms: Risk factors for alcohol-related birth defects. Drug Metab. Dispos.. 29: 562, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bosron W. F., Li T.-K.. 1987. Catalytic properties of human liver alcohol dehydrogenase isoenzymes. Enzyme. 37: 19, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Jornvall H., Hoog J.-O.. 1995. Nomenclature of alcohol dehydrogenases. Alcohol Alcoholism. 30: 153
   PubMedGoogle Scholar
• McCarver D. G., Thomasson H. R., Martier S. S., Sokol R. J., Li T.-K.. 1997. Alcohol dehydrogenase-2*3 allele protects against alcohol related birth defects among African Americans. J. Pharmacol. Exp. Ther.. 283: 1095, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bonthius D. J., Goodlett C. R., West J. R.. 1988. Blood alcohol concentration and severity of microencephaly in neonatal rats depend on the pattern of alcohol administration. Alcohol. 5: 209, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thomasson H. R., Beard J. D., Li T.-K.. 1995. ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcohol Clin. Exp. Res.. 19: 1494, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sokol R. J., Ager J., Martier S. S., Debanne S., Ernhart C., Kuzma J., Miller S.. 1986. Significant determinants of susceptibility to alcohol teratogenicity. Ann. NY Acad. Sci.. 477: 87, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hard M. L., Einarson T. R., Koren G.. 2001. The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure. Ther. Drug Monit.. 23: 427, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hu Y., Oscarson M., Johansson I., Yue Q.-Y., Dahl M.-L., Tabone M., Arinco S., Albano E., Ingelman-Sundberg M.. 1997. Genetic polymorphism of human CYP2E1: Characterization of two variant alleles. Mol. Pharmacol.. 51: 370, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rasheed A., Hines R., McCarver-May D. G.. 1997. Variation in induction of human placental CYP2E1: Possible role in susceptibility to fetal alcohol syndrome?. Toxicol. Appl. Pharmacol.. 144: 396, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ingram J. L., Stodgell C. J., Hyman S. L., Figlewicz D. A., Weitkamp L. R., Rodier P. M.. 2000. Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology. 62: 393, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wubah J. A., Ibrahim M. M., Gao X., Nguyen D., Pisano M. M., Knudsen T. B.. 1996. Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol.. 6: 60, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nicol C. J., Harrison M. L., Laposa R. R., Gimelshtein I. L., Wells P. G.. 1995. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet.. 10: 181, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Norimura T., Nomoto S., Katsuki M., Gondo Y., Kondo S.. 1996. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med.. 2: 577, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schuppe H.-C., Wieneke P., Donat S., Fritsche E., Kohn F.-M., Abel J.. 2000. Xenobiotic metabolism, genetic polymorphisms and male infertility. Andrologia. 32: 255, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Humbert R., Adler D. A., Disteche C. M., Hassett C., Omiecinski C. J., Furlong C. E.. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet.. 3: 73, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Li W.-F., Mathews C., Disteche C. M., Costa L. G., Furlong C. E.. 1997. Paraoxonase (PON 1) gene in mice: Sequencing, chromosomal localization and developmental expression. Pharmacogenetics. 7: 137, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Playfer J. R., Eze L. C., Bullen M. F., Evans D. A. P.. 1976. Genetic polymorphism and interethnic variability of plasma paroxonase activity. J. Med. Genet.. 13: 337, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mathew G., Vijayalaxmi K. K., Abdul Rahiman M.. 1992. Methyl parathion-induced sperm shape abnormalities in mouse. Mutat. Res.. 280: 169, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Abd El-Aziz M. I., Sahlab A. M., Abd El-Khalik M.. 1994. Influence of diazinon and deltamethrine on reproductive organs and fertility of male rats. Deut. Tierarztl. Wochensch. 101: 230
   PubMedGoogle Scholar
• Chou K. C., Cook R. M.. 1994. Paraoxon inhibits fertilization of mouse gametes in vitro. Bull. Environ. Contam. Toxicol.. 53: 863, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Padungtod C., Lasley B. L., Christiani D. C., Ryan L. M., Xu X.. 1998. Reproductive hormone profile among pesticide factory workers. J. Occup. Environ. Med.. 40: 1038, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Padungtod C., Niu T., Wang Z., Savitz D. A., Christiani D. C., Ryan L. M., Xu X.. 1999. Paraoxonase polymorphism and its effect on male reproductive outcomes among Chinese pesticide factory workers. Am. J. Ind. Med.. 36: 379, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Padungtod C., Hassold T. J., Millie E., Ryan L. M., Savitz D. A., Christiani D. C., Xu X.. 1999. Sperm aneuploidy among Chinese pesticide factory workers: Scoring by the FISH method. Am. J. Ind. Med.. 36: 230, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Padungtod C., Savitz D. A., Overstreet J. W., Christiani D. C., Ryan L. M., Xu X.. 2000. Occupational pesticide exposure and semen quality among chinese workers. J. Occup. Environ. Med.. 42: 982, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McKenna N. J., Lanz R. B., O'Malley B. W.. 1999. Nuclear receptor coregulators: Cellular and molecular biology. Endocr. Rev.. 20: 321, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Brinkmann A. O., Trapman J.. 2000. Genetic analysis of androgen receptors in development and disease. Adv. Pharmacol.. 47: 317, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Loy C. J., Yong E. L.. 2001. Sex, infertility and the molecular biology of the androgen receptor. Curr. Opin. Obstet. Gyn.. 13: 315, [CROSSREF]
   PubMedGoogle Scholar
• Tut T. G., Ghadessy F. J., Trifiro M., Pinsky L., Yong E. L.. 1997. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocr. Metab.. 82: 3777, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dowsing A. T., Yong E. L., Clark M., McLachlan R. I., de, Kretser D. M., Trounson A. O.. 1999. Linkage between male infertility and trinucleotide repeat expansion in the androgen receptor gene. Lancet. 354: 640, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Legius E., Vanderschueren D., Spiessens C., D'Hooghe T., Matthijs G.. 1999. Association between CAG repeat number in the androgen receptor and male infertility in a Belgian study. Clin. Genet.. 56: 166, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Yoshida K.-I., Yano M., Chiba K., Honda M., Kitahara S.. 1999. CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia. Urology. 54: 1078, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Patrizio P., Leonard D. G. B., Chen K.-L., Hernandez-Ayup S., Trounson A. O.. 2001. Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J. Androl.. 22: 444, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• von, Eckardstein S., Syska A., Gromoll J., Kamischke A., Simoni M., Nieschlag E.. 2001. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J. Clin. Endocr. Metab.. 86: 2585, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wallerand H., Remy-Martin A., Chabannes E., Bermont L., Adessi G.-L., Bittard H.. 2001. Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility. Fertil. Steril.. 76: 769, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mifsud A., Sim C. K. S., Boettger-Tong H., Moreira S., Lamb D. J., Lipshultz L. I., Yong E. L.. 2001. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: Molecular markers of risk for male infertility. Fertil. Steril.. 75: 275, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Giwercman Y. L., Xu C., Arver S., Pousette A., Reneland R.. 1998. No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin. Genet.. 54: 435, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Dadze S., Wieland C., Jakubiczka S., Funke K., Schroder E., Royer-Pokora B., Willers R., Wieacker P. F.. 2000. The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin. Mol. Hum. Reprod.. 6: 207, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Sasagawa I., Suzuki Y., Ashida J., Nakada T., Muroya K., Ogata T.. 2001. CAG repeat length analysis and mutation screening of the androgen receptor gene in Japanese men with idiopathic azoospermia. J. Androl.. 22: 804, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Irvine R., Yu M. C., Ross R. K., Coetzee G.. 1995. The CAG and GGC microsatellites of the androgen receptor are in linkage disequilibrium in men with prostate cancer. Cancer Res.. 55: 1937, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H.. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352: 77, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chamberlain N. L., Driver E. D., Miesfeld R. L.. 1994. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res.. 22: 3181, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Choong C. S., Kemppainen J. A., Zhou Z., Wilson E. M.. 1996. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol.. 10: 1527, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Irvine R., Ma H., Yu M. C., Ross R. K., Stallcup M. R., Coetzee G.. 2000. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum. Mol. Genet.. 9: 267, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shimohata T., Nakajima T., Yamada M., Uchida C., Onodera O., Naruse S., Kimura T., Koide R., Nozaki K., Sano Y., Ishiguro H., Sakoe K., Ooshima T., Sato A., Ikeuchi T., Oyake M., Sato T., Aoyagi Y., Hozumi I., Nagatsu T., Takiyama Y., Nishizawa M., Goto J., Kanasawa I., Davidson I., Tanese N., Takahashi H., Tsuji S.. 2000. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet.. 26: 29, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Muroya K., Sasagawa I., Suzuki Y., Nakada T., Ishii T., Ogata T.. 2001. Hypospadias and the androgen receptor gene: Mutation screening and CAG repeat length analysis. Mol. Hum. Reprod.. 7: 409, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ishii T., Sato S., Kosaki K., Sasaki G., Muroya K., Ogata T., Matsuo N.. 2001. Micropenis and the AR gene: Mutation and CAG repeat-length analysis. J. Clin. Endocr. Metab.. 86: 5372, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Schoenberg M. P., Hakimi J. M., Wang S., Bova G. S., Epstein J. I., Fischbeck K. H., Isaacs W. B., Walsh P. C., Barrack E. R.. 1994. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun.. 198: 74, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Green J. M., Ballou D. P., Matthews R. G.. 1988. Examination of the role of methylenetetrahydrofolate reductase in incorporation of methyltetrahydrofolate into cellular metabolism. FASEB J.. 2: 42, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bailey L. B., Gregory J. F.. 1999. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J. Nutr.. 129: 919, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rosenberg I. H., Rosenberg L. E.. 1998. The implications of genetic diversity for the nutrient requirements: The case of folate. Nutr. Rev.. 56: S47, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Perry I. J., Refsum H., Morris R. W., Ebrahim S. B., Ueland P. M., Shaper A. C.. 1995. Prospective study of serum total homocysteine concentrations and risk of stroke in middle aged British men. Lancet. 346: 1395, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Petri M., Roubenhoff R., Dallal G. E., Nadeau M. R., Selhub J., Rosenberg I. H.. 1996. Plasma homocysteine as a risk factor for atherothrombotic events in systematic lupus erythematosus. Lancet. 348: 1120, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Malinow M. R., Nieto F. J., Szklo M., Chambless L. E., Bond G.. 1993. Carotid artery intimal–medial thickening and plasma homocysteine in asymptomatic adults: The Atherosclerosis Risk in Communities Study. Circulation. 87: 1107, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Selhub J., Jacques P. F., Boston A. G., D'Agostino R. B., Wilson P. W., Belanger A. J., O'Leary D. H., Wolf P. A., Schaefer E. J., Rosenberg I. H.. 1995. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis. N. Engl. J. Med.. 332: 286, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Robillard P. Y.. 2002. Interest in preeclampsia for researchers in reproduction. J. Reprod. Immunol.. 53: 279, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Isler C. M., Martin J. N., Jr.. 2002. Preeclampsia: Pathophysiology and practice considerations for the consulting nephrologist. Semin. Nephrol.. 22: 54, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Redman C. W., Sargent I. L.. 2001. The pathogenesis of pre-eclampsia. Gynecol. Obstet. Fertil.. 29: 518, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Harger J. H., Archer D. F., Marchese S. G., Muracca-Clemens M., Garver K.. 1983. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet. Gynecol.. 62: 574, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dlugosz L., Belanger K., Hellenbrand K., Holford T., Leaderer B., Bracken M. B.. 1996. Maternal caffeine consumption and spontaneous abortion: A prospective cohort study. Epidemiology. 7: 250, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cummings A. M.. 1990. Toxicological mechanisms of implantation failure. Fundam. Appl. Toxicol.. 15: 571, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kupferminc M. J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., Fait G., Lessing J. B.. 1999. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med.. 340: 9, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Grandone E., Margaglione M., Colaizzo D., Cappucci G., Paladini D., Martinelli P., Montanaro S., Pavone G., Di, Minno G.. 1997. Factor V Leiden, C→T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb. Haemostasis. 77: 1052
   PubMed Web of Science ®Google Scholar
• Sohda S., Arinami T., Hamada H. Yamada, Hamaguchi H., Kubo T.. 1997. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J. Med. Genet.. 34: 525, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Van der, Molen E. F., Arends G. E., Nelen W. L., van der, Put N. J., Heil S. G., Eskes T. K., Blom H. J.. 2000. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am. J. Obstet. Gynecol.. 182: 1258, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zusterzeel P. L., Visser W., Blom H. J., Peters W. H., Heil S. G., Steegers E. A.. 2000. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens. Pregnancy. 19: 299, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kim Y. J., Williamson R. A., Murray J. C., Andrews J., Pietscher J. J., Peraud P. J., Merrill D. C.. 2001. Genetic susceptibility to preeclampsia: Roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am. J. Obstet. Gynecol.. 184: 1211, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Prasmusinto D., Skrablin S., Hofstaetter C., Fimmers R., van der, Ven K.. 2002. The methylenetetrahydrofolate reductase 677 C→T polymorphism and preeclampsia in two populations. Obstet. Gynecol.. 99: 1085, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rajkovic A., Mahomed K., Rozen R., Malinow M. R., King I. B., Williams M. A.. 2000. Methylenetetrahydrofolate reductase 677 C→T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol. Genet. Metab.. 69: 33, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kobashi G., Yamada H., Asano T., Nagano S., Hata A., Kishi R., Fujimoto S., Kondo K.. 2000. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am. J. Med. Genet.. 93: 122, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Powers R. W., Minich L. A., Lykins D. L., Ness R. B., Crombleholme W. R., Roberts J.. 1999. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J. Soc. Gynecol. Invest.. 6: 74, [CROSSREF]
   PubMedGoogle Scholar
• Nelen W. L., Steegers E. A., Eskes T. K., Blom H. J.. 1997. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet. 350: 861, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nelen W. L., Blom H. J., Steegers E. A., den, Heijer M., Eskes T. K.. 2000. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil. Steril.. 74: 1196, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ray J. G., Laskin C. A.. 1999. Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta. 20: 519, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Unfried G., Griesmacher A., Weismuller W., Nagele F., Huber J. C., Tempfer C. B.. 2002. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet. Gynecol.. 99: 614, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gebhardt G. S., Scholtz C. L., Hillermann R., Odendaal H. J.. 2001. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur. J. Obstet. Gyn. Res. Bull.. 97: 174, [CROSSREF]
   PubMedGoogle Scholar
• Isotalo P. A., Wells G. A., Donnelly J. G.. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am. J. Hum. Genet.. 67: 986, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zetterberg H., Regland B., Palmer M., Ricksten A., Palmqvist L., Rymo L., Arvanitis D. A., Spandidos D. A., Blennow K.. 2002. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur. J. Hum. Genet.. 10: 113, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Grandone E., Margaglione M., Colaizzo D., D'Addedda M., D'Andrea G., Pavone G.. 1998. Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss. Thromb. Haemostasis. 79: 1056
   PubMedGoogle Scholar
• Holmes Z. R., Regan L., Chilcott I., Cohen H.. 1999. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br. J. Haematol.. 105: 98, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Knapen M. F. C., Zusterzeel P. L., Peters W. H.. 1999. Glutathione and glutathione-related enzymes in reproduction. A review. Eur. J. Obstet. Gyn. Res. Bull.. 82: 171, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nebert D. W.. 2000. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants. Clin. Chem. Lab. Med.. 38: 857, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wang X., Chen D., Niu T., Wang Z., Wang L., Ryan L. M., Smith T., Christiani D. C., Zuckerman B., Xu X.. 2000. Genetic susceptibility to benzene and shortened gestation: Evidence of gene-environment interaction. Am. J. Epidemiol.. 152: 693, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Crofts F., Taioli E., Trachman J., Cosma G. N., Currie D., Toniolo P., Garte S. J.. 1994. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 15: 2961, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Xu X., Cho S.-I., Sammel M., You L., Cui S., Huang Y., Ma G., Padungtod C., Pothier L., Niu T., Christiani D. C., Smith T., Ryan L. M., Wang L.. 1998. Association of petrochemical exposure with spontaneous abortion. Occup. Environ. Med.. 55: 31, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ungvary G., Tatrai E.. 1985. On the embryotoxic effects of benzene and its alkyl derivatives in mice, rats, and rabbits. Arch. Toxicol. Suppl.. 8: 425, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wang X., Zuckerman B., Pearson C., Kaufman G., Chen C., Wang G., Niu T., Wise P. H., Bauchner H., Xu X.. 2002. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. J. Am. Med. Assoc.. 287: 195, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pollack H., Lantz P. M., Frohna J. G.. 2000. Maternal smoking and adverse birth outcomes among singletons and twins. Am J. Public Health. 90: 395, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B.. 1994. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J.. 300: 271, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Windham G. C., Swan S. H., Fenster L.. 1992. Parental cigarette smoking and the risk of spontaneous abortion. Am. J. Epidemiol.. 135: 1394, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zusterzeel P. L., Nelen W. L. D., Roelofs H. J., Peters W. H. M., Blom H. J., Steegers E. A.. 2000. Polymorphisms in biotransformation enzymes and the risk for recurrent pregnancy loss. Mol. Hum. Reprod.. 6: 474, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zusterzeel P. L., Visser W., Peters W. H., Merkus H. W., Nelen W. L. D.. 2000. Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia. Obstet. Gynecol.. 96: 50, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zusterzeel P. L., Peters W. H., De Bruyn M. A. H., Knapen M. F., Merkus H. M., Steegers E. A.. 1999. Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies. Obstet. Gynecol.. 94: 1033, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rasmussen S. A., Lammer E. J., Shaw G. M., Finnell R. H., McGehee R. E., Jr., Gallagher M., Romitti P. A., Murray J. C.. National Birth Defects Prevention Study, 2002. Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology. 66: 177, [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar